Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation

Journal of Lipid Research

Volumn 54, Issue 5, 2013, Pages 1265-1274

  Bot, Martine ^a   De Jager, Saskia C A ^a   MacAleese, Luke ^b   Lagraauw, H Maxime ^a   Van Berkel, Theo J C ^a   Quax, Paul H A ^c,d   Kuiper, Johan ^a   Heeren, Ron M A ^b   Biessen, Erik A L ^c   Bot, Ilze ^a,d  

^a LEIDEN UNIVERSITY   (Netherlands)

^b FOM INSTITUTE AMOLF   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; Macrophage; Plaque stability

Indexed keywords

CROMOGLYCATE DISODIUM; LYSOPHOSPHATIDIC ACID; TRYPTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BIOACCUMULATION; BLEEDING; BLOOD VESSEL PERMEABILITY; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; ENZYME RELEASE; IN VITRO STUDY; IN VIVO STUDY; INTRAPLAQUE HEMORRHAGE; MACROPHAGE ACTIVATION; MALE; MASS SPECTROMETRY; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULITIS;

ANIMALS; APOPTOSIS; CAROTID ARTERIES; CELLS, CULTURED; CROMOLYN SODIUM; INFLAMMATION; LYSOPHOSPHOLIPIDS; MACROPHAGES; MAST CELLS; MICE; PLAQUE, ATHEROSCLEROTIC; TRYPTASES;

EID: 84876799141     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M032862     Document Type: Article

References (39)

1. Shah, P. K. 2003. Mechanisms of plaque vulnerability and rupture. J. Am. Coll. Cardiol. 41 : 15S-22S.
2. Libby, P. 2002. Inflammation in atherosclerosis. Nature. 420 : 868-874.
3. Weber, C., A. Zernecke, and P. Libby. 2008. The multifaceted contributions of leukocyte subsets to atherosclerosis: Lessons from mouse models. Nat. Rev. Immunol. 8 : 802-815.
4. Kaartinen, M., A. Pentillä, and P. T. Kovanen. 1994. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation. 90 : 1669-1678.
5. Laine, P., M. Kaartinen, A. Pentillä, P. Panula, T. Paavonen, and P. T. Kovanen. 1999. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation. 99 : 361-369.
6. Bot, I., S. C. A. de Jager, A. Zernecke, K. A. Lindstedt, T. J. C. van Berkel, C. Weber, and E. A. L. Biessen. 2007. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation. 115 : 2516-2525.
7. Sun, J., G. K. Sukhova, P. J. Wolters, L. A. MacFarlane, P. Libby, C. Sun, Y. Zhang, J. Liu, T. L. Ennis, R. Knispel, et al. 2007. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat. Med. 13 : 719-724.
8. Healicon, R. M., and J. C. Foreman. 1985. Rat mast cell activation and inactivation: Differences when various ligands are used to induce secretion. Agents Actions. 16 : 155-159.
9. Bot, I., S. C. de Jager, M. Bot, S. H. van Heiningen, P. de Groot, R. W. Veldhuizen, T. J. van Berkel, J. H. von der Thüsen, and E. A. Biessen. 2010. The neuropeptide substance P mediates adventitial mast cell activation and induces intraplaque hemorrhage in advanced atherosclerosis. Circ. Res. 106 : 89-92.
10. Johnson, A. R., T. E. Hugli, and H. J. Müller-Eberhard. 1975. Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology. 28 : 1067-1080.
11. Wang, J., X. Cheng, M. X. Xiang, M. Alanne-Kinnunen, J. A. Wang, H. Chen, A. He, X. Sun, Y. Lin, T. T. Tang, et al. 2011. IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe α /α mice. J. Clin. Invest. 121 : 3564-3577.
12. Lappalainen, J., K. A. Lindstedt, R. Oksjoki, and P. T. Kovanen. 2011. OxLDL-IgG immune complexes induce expression and secretion of proatherogenic cytokines by cultured human mast cells. Atherosclerosis. 214 : 357-363.
13. Laine, P., A. Naukkarinen, L. Heikkilä, A. Penttilä, and P. T. Kovanen. 2000. Adventitial mast cells connect with sensory nerve fi bers in atherosclerotic coronary arteries. Circulation. 101 : 1665-1669.
14. Oksjoki, R., P. Laine, S. Helske, P. Vehmaan-Kreula, M. I. Mäyränpää, P. Gasque, P.T. Kovanen, and M. O. Pentikäinen. 2007. Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques. Atherosclerosis. 195 : 90-99.
15. Liao, L., and D. N. Granger. 1996. Role of mast cells in oxidized low-density lipoprotein-induced microvascular dysfunction. Am. J. Physiol. 271 : H1795-H1800.
16. Kelley, J., G. Hemontolor, W. Younis, C. Li, G. Krishnaswamy, and D. S. Chi. 2006. Mast cell activation by lipoproteins. Methods Mol. Biol. 315 : 341-348.
17. Hashimoto, T., H. Ohata, and K. Honda. 2006. Lysophosphatidic acid induces plasma exudation and histamine release in mice via lysophosphatidic acid receptors. J. Pharmacol. Sci. 100 : 82-87.
18. Bagga, S., K. S. Price, D. A. Lin, D. S. Friend, K. F. Austen, and J. A. Boyce. 2004. Lysophosphatidic acid accelerates the development of human mast cells. Blood. 104 : 4080-4087.
19. Lin, D. A., and J. A. Boyce. 2005. IL-4 regulates MEK expression required for lysophophatidic acid-mediated chemokine generation by human mast cells. J. Immunol. 175 : 5430-5438.
20. Siess, W., K. J. Zangl, M. Essler, M. Bauer, R. Brandl, C. Corrinth, R. Bittman, G. Tigyi, and M. Aepfelbacher. 1999. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 96 : 6931-6936.
21. Bot, M., I. Bot, R. Lopez-Vales, C. H. van de Lest, J. S. Saulnier-Blache, J. B. Helms, S. David, T. J. C. van Berkel, and E. A. L. Biessen. 2010. Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation. Am. J. Pathol. 176 : 3073-3084.
22. Cui, M. Z. 2011. Lysophosphatidic acid effects on atherosclerosis and thrombosis. Clin. Lipidol. 6 : 413-426.
23. Rizza, C., N. Leitinger, J. Yue, D. J. Fischer, D. A. Wang, P. T. Shih, H. Lee, G. Tigyi, and J. A. Berliner. 1999. Lysophosphatidic acid as a regulator of endothelial/leukocyte interaction. Lab. Invest. 79 : 1227-1235.
24. Zhou, Z., P. Subramanian, G. Sevilmis, B. Globke, O. Soehnlein, E. Karshovska, R. Megens, K. Heyll, J. Chun, J. S. Saulnier-Blache, et al. 2011. Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium. Cell Metab. 13 : 592-600.
25. von der Thüsen, J. H., T. J. C. van Berkel, and E. A. L. Biessen. 2001. Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation. 103 : 1164-1170.
26. Altelaar, A. F., I. Klinkert, K. Jalink, R. P. de Lange, R. A. Adan, R. M. Heeren, and S. R. Piersma. 2006. Gold-enhanced biomolecular surface imaging of cells and tissue by SIMS and MALDI mass spectrometry. Anal. Chem. 78 : 734-742.
27. Tahallah, N., A. Brunelle, S. De La Porte, and O. Laprévote. 2008. Lipid mapping in human dystrophic muscle by cluster-time-offl ight secondary ion mass spectrometry imaging. J. Lipid Res. 49 : 438-454.
28. Koh, J. S., W. Lieberthal, S. Heydrick, and J. S. Levine. 1998. Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway. J. Clin. Invest. 102 : 716-727.
29. Lätti, S., M. Leskinen, N. Shiota, Y. Wang, P. T. Kovanen, and K. A. Lindstedt. 2003. Mast cell-mediated apoptosis of endothelial cells in vitro: A paracrine mechanism involving TNF-alpha-mediated down-regulation of bcl-2 expression. J. Cell. Physiol. 195 : 130-138.
30. Tabas, I. 2010. Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 10 : 36-46.
31. Leskinen, M., Y. Wang, D. Leszczynski, K. A. Lindstedt, and P. T. Kovanen. 2001. Mast cell chymase induces apoptosis of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 21 : 516-522.
32. den Dekker, W. K., D. Tempel, I. Bot, E. A. L. Biessen, J. A. Joosten, M. G. Netea, J. W. van der Meer, C. Cheng, and H. J. Duckers. 2012. Mast cells induce vascular smooth muscle cell apoptosis via a tolllike receptor 4 activation pathway. Arterioscler. Thromb. Vasc. Biol. 32 : 1960-1969.
33. Zhang, J., J. Sun, J. S. Lindholt, G. K. Sukhova, M. Sinnamon, R. L. Stevens, R. Adachi, P. Libby, R. W. Thompson, and G-P. Shi. 2011. Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation. Circ. Res. 108 : 1316-1327.
34. Ishdorj, G., B. A. Graham, X. Hu, J. Chen, J. B. Johnston, X. Fang, and S. B. Gibson. 2008. Lysophosphatidic acid protects cancer cells from histone deacetylase (HDAC) inhibitor-induced apoptosis through activation of HDAC. J. Biol. Chem. 283 : 16818-16829.
35. Llodrá, J., V. Angeli, J. Liu, E. Trogan, E. A. Fisher, and G. J. Randolph. 2004. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl. Acad. Sci. USA. 101 : 11779-11784.
36. Schramm, R., T. Schaefer, M. D. Menger, and H. Thorlacius. 2002. Acute mast cell-dependent neutrophil recruitment in the skin is mediated by KC and LFA-1: Inhibitory mechanisms of dexamethasone. J. Leukoc. Biol. 72 : 1122-1132.
37. Boring, L., J. Gosling, M. Cleary, and I. F. Charo. 1998. Decreased lesion formation in CCR2 α /α mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394 : 894-897.
38. Tokumura, A., J. Sinomiya, S. Kishimoto, T. Tanaka, K. Kogure, T. Sugiura, K. Satouchi, K. Waku, and K. Fukuzawa. 2002. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids. Biochem. J. 365 : 617-628.
39. Schober, A., and W. Siess. 2012. Lysophosphatidic acid in atherosclerotic diseases. Br. J. Pharmacol. 167 : 465-482.